Taglntm1(cre/ERT2)Feil
Targeted Allele Detail
|
Symbol: |
Taglntm1(cre/ERT2)Feil |
Name: |
transgelin; targeted mutation 1, Robert Feil |
MGI ID: |
MGI:2389040 |
Synonyms: |
SM22alphaCew-ERT2, SM-Cre ERT2(ki), SM-CreERT2(ki), SM-CreERT2(ki), Taglntm1(cre/ESR1)Feil |
Gene: |
Tagln Location: Chr9:45840926-45847356 bp, - strand Genetic Position: Chr9, 25.36 cM
|
Alliance: |
Taglntm1(cre/ERT2)Feil page
|
|
|
Allele Type: |
|
Targeted (Inducible, Recombinase) |
Inducer: |
|
tamoxifen |
Mutation: |
|
Insertion
|
|
|
Taglntm1(cre/ERT2)Feil expression driven by
1 gene
Knock-in expression driven by:
Organism |
Driver Gene |
Note |
mouse |
Tagln (MGI:106012) |
|
|
|
|
Mutation details: An allele encoding a tissue specific and ligand dependent recombinase was generated by inserting cre recombinase/modified estrogen receptor (ESR1) fusion sequence into the endogenous allele. The ESR1 sequence contained engineered missense mutations at positions 400, 543, 540 which substituted the ability to bind the endogenous ligand with the ability to bind tamoxifen (J:79835). Histochemical analysis of mutant mice treated with tamoxifen showed expression of cre in smooth muscle tissue.
(J:69325)
|
|
|
Activity: |
Tissue activity of this recombinase allele
|
Driver:
|
Tagln
(mouse)
|
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
Carrying any Tagln Mutation: |
26 strains or lines available
|
|
Original: |
J:69325 Kuhbandner S, et al., Temporally controlled somatic mutagenesis in smooth muscle. Genesis. 2000 Sep;28(1):15-22 |
All: |
36 reference(s) |
|